SG162803A1 - Imidazole based lxr modulators - Google Patents

Imidazole based lxr modulators

Info

Publication number
SG162803A1
SG162803A1 SG201004272-9A SG2010042729A SG162803A1 SG 162803 A1 SG162803 A1 SG 162803A1 SG 2010042729 A SG2010042729 A SG 2010042729A SG 162803 A1 SG162803 A1 SG 162803A1
Authority
SG
Singapore
Prior art keywords
compounds
lxr modulators
imidazole based
based lxr
modulators
Prior art date
Application number
SG201004272-9A
Other languages
English (en)
Inventor
Brett B Busch
Brenton T Flatt
Xiao-Hui Gu
Shao-Po Lu
Richard Martin
Raju Mohan
Michael Charles Nyman
Edwin Schweiger
William C Stevens Jr
Tie-Lin Wang
Yinong Xie
Original Assignee
Exelixis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Exelixis Inc filed Critical Exelixis Inc
Publication of SG162803A1 publication Critical patent/SG162803A1/en

Links

SG201004272-9A 2005-06-27 2006-06-26 Imidazole based lxr modulators SG162803A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US69437205P 2005-06-27 2005-06-27

Publications (1)

Publication Number Publication Date
SG162803A1 true SG162803A1 (en) 2010-07-29

Family

ID=39947886

Family Applications (1)

Application Number Title Priority Date Filing Date
SG201004272-9A SG162803A1 (en) 2005-06-27 2006-06-26 Imidazole based lxr modulators

Country Status (3)

Country Link
CN (2) CN101248049B (zh)
SG (1) SG162803A1 (zh)
ZA (1) ZA200710582B (zh)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2620451T3 (es) * 2009-05-28 2017-06-28 Exelixis Patent Company Llc Moduladores de los LXR
EP2395003A1 (en) * 2010-05-27 2011-12-14 Laboratorios Del. Dr. Esteve, S.A. Pyrazole compounds as sigma receptor inhibitors
AR088728A1 (es) * 2011-03-25 2014-07-02 Bristol Myers Squibb Co Moduladores de lxr como prodroga de imidazol
HUE040231T2 (hu) 2012-03-02 2019-02-28 Ralexar Therapeutics Inc Máj X receptor (LXR) modulátorok bõrbetegségek, rendellenességek és állapotok kezelésére
CA2923178A1 (en) 2013-09-04 2015-03-12 Alexar Therapeutics, Inc. Liver x receptor (lxr) modulators for the treatment of dermal diseases, disorders and conditions
ES2804304T3 (es) 2013-09-04 2021-02-05 Ellora Therapeutics Inc Moduladores del receptor X hepático (LXR)
WO2016131810A1 (en) * 2015-02-20 2016-08-25 Bayer Pharma Aktiengesellschaft N-phenyl-(morpholin-4-yl or piperazinyl)acetamide derivatives and their use as inhibitors of the wnt signalling pathways
CN105001210B (zh) * 2015-07-06 2017-11-28 南京大学 一类含甲硝唑骨架的吡唑硝基咪唑衍生物、其制备方法及应用
CN106543092B (zh) * 2016-10-14 2019-05-17 华东师范大学 1,5-二芳香基-1,2,4-三氮唑类化合物及其制药用途
EA202091101A1 (ru) * 2017-11-01 2020-08-06 Бристол-Маерс Сквибб Компани Спироциклические соединения в качестве модуляторов фарнезоидного x-рецептора
CN113527281B (zh) * 2020-04-20 2023-12-22 昆山彭济凯丰生物科技有限公司 杂环化合物及其制备方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2179254T3 (es) * 1996-11-04 2003-01-16 Bayer Cropscience Sa 1-poliarilpirazoles plaguicidas.
WO2004011446A1 (en) * 2002-07-26 2004-02-05 Bayer Pharmaceuticals Corporation Indane, dihydrobenzofuran, and tetrahydronaphthalene carboxylic acid derivatives and their use as antidiabetics
TWI324596B (en) * 2002-08-26 2010-05-11 Nat Health Research Institutes Imidazolamino compounds
CN1747936A (zh) * 2003-02-12 2006-03-15 特兰斯泰克制药公司 作为治疗试剂的取代吡咯衍生物
DE10315573A1 (de) * 2003-04-05 2004-10-14 Merck Patent Gmbh Substituierte Pyrazole
PT1638943E (pt) * 2003-05-27 2008-11-14 Conseils De Rech S Et D Aplica Novos derivados de imidazoles, sua preparação e sua utilização como medicamento
US20090018150A1 (en) * 2003-07-24 2009-01-15 Asterand Uk Limited 5-Ht2b Receptor Antagonists
JP2006528661A (ja) * 2003-07-25 2006-12-21 ファイザー・インク アミノピラゾール化合物およびｃｈｋ１阻害剤としての使用
US8969372B2 (en) * 2003-11-14 2015-03-03 Aptose Boisciences Inc. Aryl imidazoles and their use as anti-cancer agents

Also Published As

Publication number Publication date
CN101248049A (zh) 2008-08-20
CN101248048B (zh) 2013-08-28
CN101248049B (zh) 2013-08-28
ZA200710582B (en) 2008-12-31
CN101248048A (zh) 2008-08-20

Similar Documents

Publication Publication Date Title
MY152162A (en) Imidazole based lxr modulators
SG162803A1 (en) Imidazole based lxr modulators
HN2010001059A (es) Nuevo titulo modificado: compuestos derivados de pirimidina, un proceso para la preparacion de los mismos, una composicion farmaceutica que los comprenden y combinaciones de dichos compuestos con otros agentes.
MX2009005462A (es) Analogos de 7,8-saturados-4,5-epoxi-morfinano.
WO2007148185A3 (en) Substituted 3 -amino- pyrrolidino-4 -lactams as dpp inhibitors
MX2009005461A (es) N-oxidos de analogos de 4,5-epoxi-morfinano.
CR11036A (es) Derivados y composiciones de isoindol 4' -o- sustituidos, composiciones que las comprenden y metodos de uso de los mismos
PT2421879E (pt) Novos 7-deazapurina nucleósidos para utilizações terapêuticas
TW200745112A (en) Tricyclic benzimidazoles and their use as metabotropic glutamate receptor modulators
NO20081554L (no) Isoindollmidforbindelser og sammensetninger omfattende samme, og anvendelse derav
TW200612958A (en) Substituted imidazole derivatives
UA94833C2 (en) Substituted bicyclolactams
GB2453819A (en) Modulators of hypoxia inducible factor-1 and related uses
RS52526B (en) OXADIAZOL DERIVATIVES AND THEIR USE AS A POTENTIAL OF METABOTROPIC GLUTAMATE RECEPTORS-842
TN2011000585A1 (en) Lxr modulators
WO2007084728A3 (en) 2-imino-benzimidazoles
IL191763A0 (en) Pyrrolo [2,3-b]pyridine derivatives as h3 receptor modulators
HK1154777A1 (en) Lipoprotein lipase-activating compositions comprising benzene derivatives
TW200728298A (en) Thiophene compounds and thrombopoietin receptor activators
MX2010006882A (es) Derivado novedoso de catecol, composición farmaceutica que contiene el mismo, uso del derivado de catecol, y uso de la composición farmaceutica.
DE602004009200D1 (de) Tetrahydrochinazolinderivate als cfr-antagonisten
MX2010001566A (es) Derivado de aminopirazolamida.
WO2008116185A3 (en) Substituted pyrimidines as adenosine receptor antagonists
EP1845780A4 (en) USES OF METHYLPHENIDATE DERIVATIVES
TW200738625A (en) 3-Amino-1-arylpropyl indoles and aza-substituted indoles